Sort
53,477 grants matching “addiction”
Neuroimaging of animal models of neurologic and psychiatric disorders
$970,509Yihong Yang · National Institute On Drug Abuse · ZIA · FY2018 · DA
Animal MRI/MRS Methodological Development for Drug Addiction Applications
$970,509Yihong Yang · National Institute On Drug Abuse · ZIA · FY2018 · DA
Clinical Trials Network: Greater New York Node
$970,323Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2011 · DA
Adapting Web-based CBT to improve adherence and outcome for individuals with opioid use disorder and chronic pain treated with opioid agonists
$970,207Alicia Heapy · Yale University · R33 · FY2022 · AT
SOAR: Smartphones for Opioid Addiction Recovery
$970,164Paul W Glimcher · New York University School Of Medicine · R01 · FY2025 · DA
Presynaptic Mechanisms of Neural Plasticity
$969,563Robert H Edwards · University Of California, San Francisco · P01 · FY2008 · DA
Novel Dopamine D2 and D3 Receptor Ligands
$969,378Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2015 · DA
Novel Probes For Monoamine Transporters
$969,378Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2015 · DA
Appalachian Node
$969,141Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2023 · DA
Recovery Management Checkups for Women Offenders (RMC-WO) Experiment
$968,747Christy K Scott · Chestnut Health Systems, Inc. · R01 · FY2008 · DA
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM
$968,494Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2015 · DA
POP: 2/22/17-2/21/21. PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA. N01DA-17-8932. PURPOSE: TO EXERCISE OPTION QUANTITY 1(CO
$968,474Patrick Beardsley · Virginia Commonwealth University · N01 · FY2020 · DA
Cannabinoid CB1 and CB2 receptors and drug abuse
$968,160Zheng-Xiong Xi · National Institute On Drug Abuse · ZIG · FY2022 · DA
Rational design and targeted selection of DNA-scaffolded nicotine vaccines
$967,930Yung Chang · Arizona State University-Tempe Campus · R01 · FY2014 · DA
Development of a Commercial Platform for Discovery and Validation of Key Microbial Metabolites in CNS Disorders
$967,251Todd Z Desantis · Second Genome, Inc. · R44 · FY2020 · DA
Active Immunization for Treating Methamphetamine Abuse
$966,958S. Michael Owens · Univ Of Arkansas For Med Scis · U01 · FY2010 · DA
Mice with Functional Fluorescent Nicotinic Receptor Subunits
$966,896Henry A. Lester · California Institute Of Technology · RC2 · FY2010 · DA
Southern Consortium Node of the Clinical Trials Network
$966,685Kathleen Theresa Brady · Medical University Of South Carolina · U10 · FY2015 · DA
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders
$966,417Cindy Ann Burklow · Naprogenix, Inc · R44 · FY2022 · AA
Early Phase Pain Investigation Clinical Network: Greater New York Clinical Center
$966,075Lisa Doan · New York University School Of Medicine · U24 · FY2019 · NS
Active Immunization for Treating Methamphetamine Abuse
$965,870S. Michael Owens · Univ Of Arkansas For Med Scis · U01 · FY2011 · DA
In vivo imaging of dorsal striatum function in freely behaving mice
$965,742Da-Ting Lin · National Institute On Drug Abuse · ZIA · FY2015 · DA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$965,587Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Genetics and Progression of Early-onset Substance Dependence and HIV Risk
$965,586Christian J Hopfer · University Of Colorado Denver · R01 · FY2017 · DA
NorthStar Node of the Clinical Trials Network
$965,579Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2019 · DA